First, we found that both lncRNA DLX6‐AS1 and DLX6 were enriched in endometrial cancer tissues or cell lines, and that silencing lncRNA DLX6‐AS1 or DLX6 inhibited tumour growth and promoted apoptosis. Here, DLX6 is linked to endometrial cancer.